Literature DB >> 30451992

T cell receptor fingerprinting enables in-depth characterization of the interactions governing recognition of peptide-MHC complexes.

Amalie K Bentzen1, Lina Such1, Kamilla K Jensen2, Andrea M Marquard1, Leon E Jessen1,2, Natalie J Miller3, Candice D Church3, Rikke Lyngaa1, David M Koelle4,5, Jürgen C Becker6, Carsten Linnemann7, Ton N M Schumacher7, Paolo Marcatili2, Paul Nghiem3, Morten Nielsen2,8, Sine R Hadrup1.   

Abstract

The promiscuous nature of T-cell receptors (TCRs) allows T cells to recognize a large variety of pathogens, but makes it challenging to understand and control T-cell recognition. Existing technologies provide limited information about the key requirements for T-cell recognition and the ability of TCRs to cross-recognize structurally related elements. Here we present a 'one-pot' strategy for determining the interactions that govern TCR recognition of peptide-major histocompatibility complex (pMHC). We measured the relative affinities of TCRs to libraries of barcoded peptide-MHC variants and applied this knowledge to understand the recognition motif, here termed the TCR fingerprint. The TCR fingerprints of 16 different TCRs were identified and used to predict and validate cross-recognized peptides from the human proteome. The identified fingerprints differed among TCRs recognizing the same epitope, demonstrating the value of this strategy for understanding T-cell interactions and assessing potential cross-recognition before selection of TCRs for clinical development.

Entities:  

Year:  2018        PMID: 30451992      PMCID: PMC9452375          DOI: 10.1038/nbt.4303

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   68.164


  50 in total

1.  Counting absolute numbers of molecules using unique molecular identifiers.

Authors:  Teemu Kivioja; Anna Vähärautio; Kasper Karlsson; Martin Bonke; Martin Enge; Sten Linnarsson; Jussi Taipale
Journal:  Nat Methods       Date:  2011-11-20       Impact factor: 28.547

2.  Generation of peptide-MHC class I complexes through UV-mediated ligand exchange.

Authors:  Boris Rodenko; Mireille Toebes; Sine Reker Hadrup; Wim J E van Esch; Annemieke M Molenaar; Ton N M Schumacher; Huib Ovaa
Journal:  Nat Protoc       Date:  2006       Impact factor: 13.491

3.  Design and use of conditional MHC class I ligands.

Authors:  Mireille Toebes; Miriam Coccoris; Adriaan Bins; Boris Rodenko; Raquel Gomez; Nella J Nieuwkoop; Willeke van de Kasteele; Guus F Rimmelzwaan; John B A G Haanen; Huib Ovaa; Ton N M Schumacher
Journal:  Nat Med       Date:  2006-02-05       Impact factor: 53.440

4.  Design of 240,000 orthogonal 25mer DNA barcode probes.

Authors:  Qikai Xu; Michael R Schlabach; Gregory J Hannon; Stephen J Elledge
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-26       Impact factor: 11.205

Review 5.  A very high level of crossreactivity is an essential feature of the T-cell receptor.

Authors:  D Mason
Journal:  Immunol Today       Date:  1998-09

6.  T-cell responses to oncogenic merkel cell polyomavirus proteins distinguish patients with merkel cell carcinoma from healthy donors.

Authors:  Rikke Lyngaa; Natasja Wulff Pedersen; David Schrama; Charlotte Albæk Thrue; Dafina Ibrani; Ozcan Met; Per Thor Straten; Paul Nghiem; Jürgen C Becker; Sine Reker Hadrup
Journal:  Clin Cancer Res       Date:  2014-02-13       Impact factor: 12.531

7.  Cancer regression and neurological toxicity following anti-MAGE-A3 TCR gene therapy.

Authors:  Richard A Morgan; Nachimuthu Chinnasamy; Daniel Abate-Daga; Alena Gros; Paul F Robbins; Zhili Zheng; Mark E Dudley; Steven A Feldman; James C Yang; Richard M Sherry; Giao Q Phan; Marybeth S Hughes; Udai S Kammula; Akemi D Miller; Crystal J Hessman; Ashley A Stewart; Nicholas P Restifo; Martha M Quezado; Meghna Alimchandani; Avi Z Rosenberg; Avindra Nath; Tongguang Wang; Bibiana Bielekova; Simone C Wuest; Nirmala Akula; Francis J McMahon; Susanne Wilde; Barbara Mosetter; Dolores J Schendel; Carolyn M Laurencot; Steven A Rosenberg
Journal:  J Immunother       Date:  2013-02       Impact factor: 4.456

8.  Isolation of a Structural Mechanism for Uncoupling T Cell Receptor Signaling from Peptide-MHC Binding.

Authors:  Leah V Sibener; Ricardo A Fernandes; Elizabeth M Kolawole; Catherine B Carbone; Fan Liu; Darren McAffee; Michael E Birnbaum; Xinbo Yang; Laura F Su; Wong Yu; Shen Dong; Marvin H Gee; Kevin M Jude; Mark M Davis; Jay T Groves; William A Goddard; James R Heath; Brian D Evavold; Ronald D Vale; K Christopher Garcia
Journal:  Cell       Date:  2018-07-26       Impact factor: 41.582

9.  Improvements to robotics-inspired conformational sampling in rosetta.

Authors:  Amelie Stein; Tanja Kortemme
Journal:  PLoS One       Date:  2013-05-21       Impact factor: 3.240

10.  Structural interplay between germline interactions and adaptive recognition determines the bandwidth of TCR-peptide-MHC cross-reactivity.

Authors:  Jarrett J Adams; Samanthi Narayanan; Michael E Birnbaum; Sachdev S Sidhu; Sydney J Blevins; Marvin H Gee; Leah V Sibener; Brian M Baker; David M Kranz; K Christopher Garcia
Journal:  Nat Immunol       Date:  2015-11-02       Impact factor: 25.606

View more
  31 in total

Review 1.  T-cell receptor affinity in the age of cancer immunotherapy.

Authors:  Michele M Hoffmann; Jill E Slansky
Journal:  Mol Carcinog       Date:  2020-05-09       Impact factor: 4.784

2.  T-Scan: A Genome-wide Method for the Systematic Discovery of T Cell Epitopes.

Authors:  Tomasz Kula; Mohammad H Dezfulian; Charlotte I Wang; Nouran S Abdelfattah; Zachary C Hartman; Kai W Wucherpfennig; Herbert Kim Lyerly; Stephen J Elledge
Journal:  Cell       Date:  2019-08-08       Impact factor: 41.582

Review 3.  TCR-sequencing in cancer and autoimmunity: barcodes and beyond.

Authors:  Kristen E Pauken; Kaitlyn A Lagattuta; Benjamin Y Lu; Liliana E Lucca; Adil I Daud; David A Hafler; Harriet M Kluger; Soumya Raychaudhuri; Arlene H Sharpe
Journal:  Trends Immunol       Date:  2022-01-25       Impact factor: 16.687

4.  T-cell Receptors Engineered De Novo for Peptide Specificity Can Mediate Optimal T-cell Activity without Self Cross-Reactivity.

Authors:  Preeti Sharma; Daniel T Harris; Jennifer D Stone; David M Kranz
Journal:  Cancer Immunol Res       Date:  2019-09-23       Impact factor: 11.151

5.  Prevalent and Diverse Intratumoral Oncoprotein-Specific CD8+ T Cells within Polyomavirus-Driven Merkel Cell Carcinomas.

Authors:  Lichen Jing; Mariliis Ott; Candice D Church; Rima M Kulikauskas; Dafina Ibrani; Jayasri G Iyer; Olga K Afanasiev; Aric Colunga; Maclean M Cook; Hong Xie; Alexander L Greninger; Kelly G Paulson; Aude G Chapuis; Shailender Bhatia; Paul Nghiem; David M Koelle
Journal:  Cancer Immunol Res       Date:  2020-03-16       Impact factor: 11.151

Review 6.  Peptide mimotopes alter T cell function in cancer and autoimmunity.

Authors:  Jill E Slansky; Maki Nakayama
Journal:  Semin Immunol       Date:  2020-03-20       Impact factor: 11.130

7.  High-throughput modeling and scoring of TCR-pMHC complexes to predict cross-reactive peptides.

Authors:  Tyler Borrman; Brian G Pierce; Thom Vreven; Brian M Baker; Zhiping Weng
Journal:  Bioinformatics       Date:  2020-12-23       Impact factor: 6.937

8.  SARS-CoV-2 genome-wide T cell epitope mapping reveals immunodominance and substantial CD8+ T cell activation in COVID-19 patients.

Authors:  Ditte Stampe Hersby; Tripti Tamhane; Sunil Kumar Saini; Helle Rus Povlsen; Susana Patricia Amaya Hernandez; Morten Nielsen; Anne Ortved Gang; Sine Reker Hadrup
Journal:  Sci Immunol       Date:  2021-04-14

9.  The self-peptide repertoire plays a critical role in transplant tolerance induction.

Authors:  Eric T Son; Pouya Faridi; Moumita Paul-Heng; Mario L Leong; Kieran English; Sri H Ramarathinam; Asolina Braun; Nadine L Dudek; Ian E Alexander; Leszek Lisowski; Patrick Bertolino; David G Bowen; Anthony W Purcell; Nicole A Mifsud; Alexandra F Sharland
Journal:  J Clin Invest       Date:  2021-11-01       Impact factor: 14.808

Review 10.  T Cell Specificity: A Great Challenge in Chagas Disease.

Authors:  Fátima Ferragut; Gonzalo R Acevedo; Karina A Gómez
Journal:  Front Immunol       Date:  2021-06-29       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.